The table below shows IRADIMED CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$8.29M
$4.29M
$3.88M
$4.65M
$1.43M
$943.08K
Capital expenditure
$403.00K
$3.70M
$270.57K
$6.40M
$183.35K
$132.32K
Investing cash flow
-$469.00K
-$3.92M
-$478.80K
-$6.56M
-$424.69K
-$173.93K
Dividends paid
$2.56M
$2.16M
$7.98M
$13.22M
IRMD operating cash flow (10-K history)
IRADIMED CORP reported operating cash flow of $24.95M for fiscal year 2025. That is down 2.6% from $25.62M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $9.41M (FY 2016) to $24.95M. Figures come from the company's audited annual reports as filed with the SEC.